Stay updated on MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The clinical trial record for the MK-4830 study is displayed, including its status, study design, eligibility criteria, locations, interventions, and outcome measures, replacing the error page.
    Difference
    100%
    Check dated 2026-11-08T15:22:35.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-01T16:18:09.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces a transition-related update and explains that both “Super Intelligence” and “Artificial Intelligence” may appear across NIH content.
    Difference
    1%
    Check dated 2026-10-25T16:21:14.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1. The page continues to show a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-18T16:30:40.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1; the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T16:32:16.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error in place of the study details, with the addition of standard page chrome such as a 403 header and a Home link in the navigation/footer.
    Difference
    25%
    Check dated 2026-09-20T20:00:27.000Z thumbnail image

Stay in the know with updates to MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MK-4830 Monotherapy & Combination With Pembrolizumab Clinical Trial page.